Impairing hydrolase transport machinery prevents human melanoma metastasis

Commun Biol. 2024 May 15;7(1):574. doi: 10.1038/s42003-024-06261-y.

Abstract

Metastases are the major cause of cancer-related death, yet, molecular weaknesses that could be exploited to prevent tumor cells spreading are poorly known. Here, we found that perturbing hydrolase transport to lysosomes by blocking either the expression of IGF2R, the main receptor responsible for their trafficking, or GNPT, a transferase involved in the addition of the specific tag recognized by IGF2R, reduces melanoma invasiveness potential. Mechanistically, we demonstrate that the perturbation of this traffic, leads to a compensatory lysosome neo-biogenesis devoided of degradative enzymes. This regulatory loop relies on the stimulation of TFEB transcription factor expression. Interestingly, the inhibition of this transcription factor playing a key role of lysosome production, restores melanomas' invasive potential in the absence of hydrolase transport. These data implicate that targeting hydrolase transport in melanoma could serve to develop new therapies aiming to prevent metastasis by triggering a physiological response stimulating TFEB expression in melanoma.

MeSH terms

  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors* / genetics
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors* / metabolism
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Hydrolases* / genetics
  • Hydrolases* / metabolism
  • Lysosomes* / metabolism
  • Melanoma* / genetics
  • Melanoma* / metabolism
  • Melanoma* / pathology
  • Neoplasm Metastasis
  • Protein Transport
  • Receptor, IGF Type 2 / genetics
  • Receptor, IGF Type 2 / metabolism